key: cord-0778480-vpl0ryy4
authors: Greensmith, T.S.W.; Faulkner, A. C.; Davies, P.S.E.; Sinnerton, R.J.H.; Cherry, J. V.; Supparamaniam, S.; MacInnes, A.G.M.; Dalgleish, S.
title: Hip Fracture Care During 2020 COVID-19 First-Wave A Review of the Outcomes of Hip Fracture Patients at a Scottish Major Trauma Centre
date: 2021-02-25
journal: Surgeon
DOI: 10.1016/j.surge.2021.01.012
sha: 3f4e595fcc031392f95e64ea627c22d0b6afe508
doc_id: 778480
cord_uid: vpl0ryy4

BACKGROUND AND PURPOSE OF THE STUDY This study reviewed whether the response to the Coronavirus (COVID-19) pandemic affected the care for hip fracture patients at a major trauma centre in Scotland during the first-wave lock-down period. METHODS All patients referred to Orthopaedics with a hip fracture in a major trauma centre in Scotland were captured between 14 th March and 28 th May (11 weeks) in 2020 and 2019. Patients were identified using electronic patient records. The primary outcomes are time to theatre, length of admission and 30-day mortality. Secondary outcomes are COVID-19 prevalence, duration of surgery, proportion of patients to theatre within 36 hours and COVID-19 positive 30-day mortality from time of surgery. 225 patients were included: 108 from 2019 and 117 from 2020. THE MAIN FINDINGS 30-day mortality was 3.7% (n=4) in 2019 and 8.5% (n=10) in 2020 (p=0.142). There was no statistical difference with time to theatre (p=0.150) nor duration of theatre (p=0.450). Duration of admission was reduced from 12 days to 6.5 days (p=<0.005). 4 patients tested positive for COVID-19 during admission, one 5 days after discharge, all underwent surgical management. 30-day mortality for COVID-19 positive patients during admission was 40%. COVID-19 prevalence of patients that were tested (n=89) was 5.62%. CONCLUSIONS This study has shown the care of hip fracture patients has been maintained during the COVID-19 pandemic. There is no statistically significant change in mortality, time to theatre, and duration of surgery, however, the patient's admission duration was significantly less than the 2019 cohort.

Healthcare worldwide has been affected by the Coronavirus COVID-19 pandemic. Rapid service provision changes were required to care for COVID-19 patients. Along with many other countries the United Kingdom and Scottish Governments responded by mandating a national lockdown beginning on 23rd March 2020 to help reduce the spread of the virus and protect the National Health Service (NHS) from being overwhelmed. There were over 11.8 million cases worldwide and the UK had over 300,000 cases and 45,500 deaths at the time of conclusion of this study. 1, 2 The first confirmed COVID-19 case in Scotland was reported on 1st March 2020, from then the numbers rapidly increased. Just over two weeks from this date our department stopped elective work on 16th March 2020 and resource reallocated from the Trauma and Orthopaedic service, reducing our in-patient trauma capacity to a quarter of normal.

Operating theatre capacity was reduced with the main theatre environment redeployed as a COVID-19 critical care area, our normal access to two allocated orthopaedic trauma theatres reduced to one shared emergency theatre. Given this reduction in theatre capacity and increasing ever-changing barriers to get emergency admissions into theatre, there was concern that the impact on orthopaedic trauma service from COVID-19 would affect the outcomes for hip fracture patients. Furthermore, there was concern that mortality of hip J o u r n a l P r e -p r o o f fracture patients would be considerably higher in those with concomitant COVID -19 infection. 3 This study aims to review the outcomes of hip fracture patients during the Lockdown period at a major trauma centre in Scotland in comparison to the same time period in 2019. All patients who had a diagnosis of acute hip fracture identified radiographically, including intracapsular, extracapsular, intertrochanteric and subtrochanteric proximal femoral fractures, admitted directly to Trauma and Orthopaedics were included. Hip fracture diagnoses were confirmed by the primary author through radiographic evaluation using the local Picture Archiving and Communication System (PACS) radiology system. Patients referred to orthopaedics or from other specialties with missing time data were excluded. Five patients with a hip fracture, all of whom underwent surgical management, had a COVID-19 positive swab result. Only two of these patients were known positives prior to theatre. Four patients were COVID-19 positive during their admission. Of these four patients, one patient tested positive on admission who was asymptomatic and detected on the routine admission swab. One asymptomatic patient from a care home tested positive prior to surgery, despite the first swab on admission swab being negative. One patient tested positive 5 days post-operatively after developing new pyrexia with on-going cough.

One patient was tested day 2 post-operatively through the routine screening of over 70-

year-old patients and found to be positive. However, one patient was found to be positive 5 days after discharge, day 6 post-operatively, after the GP arranged for COVID-19 testing in the nursing home as the patient had a new cough.

The five patients found to be COVID-19 positive on RT-PCR testing represents 5.62% of the 2020 cohort that underwent testing; all of whom had operative management of their hip fracture. Of the 89 tested patients four died, with only 2 deaths due to active COVID-19 infection, both within 30 days of admission and both post-operatively. One Patient was suspected of COVID-19 as cause of death but was not tested.

In addition, there were five patients who had tested positive prior to their admission and were deemed recovered COVID-19 patients, who had tested positive greater than 7 days prior to admission with a range 7 -44 days.

Length of hospital stay, length of surgery and time from admission to surgery is summarised in Table 3 Table 4 .

Causes of death are summarised in Table 5 . Four patients (3.7%) died in 2019 and ten patients (8.5%) died in 2020 within 30-days of surgery. Figure 19, reporting only three positive people of more than 160 tested during their study period. 8 Our approach evolved to test all patients admitted mid-way through our study period, however, we notably did not undertake routine staff testing.

We found the prevalence of COVID-19 to be 5.62% in the patients that were tested during their admission. Although, the admission COVID-19 status of patients was not known for 23% of the cohort as they did not undergo testing. Initially, only patients that were symptomatic were screened until testing capacity increased and a routine screening policy of all trauma and orthopaedic admissions was implemented on 10th April 2020. The only patient that was found to be positive for COVID-19 on their admission swab was asymptomatic at the time of testing. The true prevalence of COVID-19, therefore, is difficult to fully quantify for the patients in this study and is likely to be underrepresented. The COVID-19 RT-PCR testing itself is known to have a high false negative rate. 9 All patients identified as COVID-19 positive underwent operative management. We had access to a 

The British Orthopaedic Association (BOA) released an emergency BOA Standards for Trauma and Orthopaedics (BOAST) Guideline at the beginning of the pandemic which moved towards more non-operative management for trauma patients to reduce the impact on service requirements. 10 Whilst the number of trauma patients reduced significantly, the number of referrals for hip fracture patients remained constant throughout the lockdown period. Whilst there was an initial move towards non-operative management for general trauma patients; the best care for hip fracture patients is operative management for early mobilisation. Conservative management for the vast majority of hip fracture cases is inappropriate. National guidance from the National Institute for Health and Care Excellence (NICE) sets out clear guidelines for the management of hip fracture patients. 11 Cronin et al suggests scoring criteria in an attempt to conservatively manage selected hip fracture patients, creating a non-operative management pathway. 12 There is no long-term outcome data for the conservative management of hip fracture patients in this study and the basis of this non-operative pathway was for a time when overall demand on healthcare outstripped supply. NHS England issued specific guidance for the management of patients with fragility fractures during the COVID-19 Pandemic with operative management for hip fracture patients still advised. 13 The Faculty of Intensive Care Medicine (ICM) Anaesthesia COVID-19 Group published strong guidance stating medical and surgical management of patients with hip fracture should, as far as possible, remain unchanged from that offered before the pandemic. 14 COVID-19 has significantly impacted the provision of surgical care to patients during the peak of the pandemic with reduction in surgical capacity through requisition of resource, reallocation of staff to critical care for COVID-19 patients. Utilisation and efficiency of J o u r n a l P r e -p r o o f trauma lists has become even more important. Time to theatre within 36 hours is a key performance indicator for the care of hip fracture patients. 11 We have shown no statistically significant difference in the time to theatre from admission with the overall 2020 cohort as compared to 2019. However, there was an observed increase in time to theatre for patients known to be COVID-19 positive, although numbers in each subgroup were small. There were numerous factors which were all felt to contribute to a perceived sense of general decreased productivity in surgical provision for patients. These included decreased theatre availability, constantly evolving patient pathways and swabbing criteria, increased use of PPE, more vigorous cleaning of theatre after each case and scrutiny of air change requirements within the theatre. It is reassuring that despite the changes to care and indirect effects of COVID-19, outcomes have not been compromised for the hip fracture population. This is likely a reflection of the collective prioritization of these patients, and a continual pressure to overcome any barriers which were hindering safe and expeditious care of hip fracture patients.

One of the main findings is a statistically significant reduction in the length of stay in patients with hip fractures from an average of 12.0 to 6.5 days. There has been a push to reduce the time patients spend in hospital to reduce possible exposure to COVID-19 and potential nosocomial infection. Shorter length of stay has been shown to reduce the risk of hip fracture patients acquiring any nosocomial infection. 15 Longer length of stay is associated with higher patient care cost and has been shown to have increased odds of death at 30-days after discharge. 16 Therefore, the COVID-19 cohort of patients may have actually benefited from the change of service and reduction in length of stay in hospital as a result. We were able to benefit from an increased provision of in-patient physiotherapy J o u r n a l P r e -p r o o f from outpatient physiotherapists who were redeployed to the Orthopaedic wards as their routine clinical activities had been cancelled. Patients were discharged to peripheral hospitals away from the regional centre which managed the care of COVID-19 positive patients, however, the number of patients discharged to down-stream hospitals remained similar to the previous year.

More patients in 2020 were discharged to a nursing home (2020: 27, 2019: 10), with fewer patients discharged to their own home in 2019 (2020: 25, 2019: 48). However, what is not clear is whether these patients were discharged to a care home because of reduced community care availability. Unfortunately, we have not been able to ascertain this for the patients included in this study. There is concern that a patient who resides in a nursing home may have a higher risk of contracting COVID-19 than in hospital and may be at higher risk from an earlier discharge back to care. Currently, there is no robust evidence that this is the case and would be an interesting point for further study.

There were concerns reported early in the pandemic in both elective and emergency surgical setting regarding general anaesthesia and surgical morbidity associated with perioperative COVID-19 infection. 17 Thirty-day mortality appears to increase from 3.7% in 2019 to 8.5% in 2020, but this is not statistically significant (P=0.142). Amongst patients who died, it was found that time to theatre had increased between 2019 (27 hours) and 2020 (40 hours). We found that of the five patients found to be COVID-19 positive, that two patients date. However, this is a small patient cohort, and the authors remark it is unclear why this is lower than other reported mortality rates.

Internationally, the COVIDSURG international project published the first internal multicentre study related to post-operative 30-day mortality and showed that for all orthopaedic operative patients the rate of mortality was 28.8%. 20 There are a number of limitations to this study. The main limitation is low patient numbers in the cohorts of our single centre study, with low COVID-19 positive case numbers in the 2020 cohort and the overall number of deaths was small. A larger study would be required to review mortality data in greater detail. The data collection for the 2019 cohort was retrospective. We excluded patients from analysis that were referred whilst in hospital from J o u r n a l P r e -p r o o f other specialties due to incomplete time data. At the beginning of the lockdown period, not all patients being admitted were routinely tested for COVID-19 which likely causes an under representation of the true number of COVID-19 infected patients. We do not have the local data on the sensitivity or specificity of the COVID-19 RT-PCR testing for the duration of this study period.

In the future, and whilst in the midst of the second wave, we must be clear that the care of elderly frail patients that sustain hip fractures must not be compromised. It may be that COVID-19 continues for many more months, perhaps into years, and appropriate risk assessment, robust patient pathways and an efficient testing system should be implemented to optimise the possible outcomes for this patient cohort. The appropriate use of Personal Protective Equipment and the use of a designated COVID-19 positive operating theatre can mitigate the risk to medical staff involved in the patient's operative care. Rapid testing of all patients to promptly detect positive patients allows risk stratification; the patients pre-operative condition to be optimised in the correct admission pathway; and appropriate shared decision making between involved specialities and family members. Therefore, efficiently identifying the COVID-19 status of the patients could allow expeditious surgery so that lengthy delays to theatre are not an additive factor to a worse outcome and increased mortality. 

Coronavirus (COVID-19) in the UK

Timeline of WHO's response to COVID-19

IMPACT-Scot report on COVID-19 and hip fractures

Italy and COVID-19: The changing patient flow in an orthopedic trauma center emergency department

Proximal femur fractures in covid-19 emergency: The experience of two orthopedics and traumatology departments in the first eight weeks of the Italian epidemic

Increased Mortality and Major Complications in Hip Fracture Care During the COVID-19

New York City Perspective

The effects of COVID-19 on perioperative morbidity and mortality in patients with hip fractures

COVID-19 strategy in organizing and planning orthopedic surgery in a major orthopedic referral center in an area of Italy severely affected by the pandemic: Experience of the Department of Orthopedics, University of Padova

Interpreting a covid-19 test result

Emergency BOAST: Management of patients with urgent orthopaedic conditions and trauma during the coronavirus pandemic

Hip Fracture: management (CG124)

COVID-19 causes a SHiFT in the sands for proximal femoral fracture management?

Clinical guide for the perioperative care of people with fragility fractures during the Coronavirus pandemic

ICM Anaesthesia COVID-19. Guidance on perioperative management of patients with fragility fractures -ICM Anaesthesia

Quality of Care in Hip Fracture Patients: The Relationship Between Adherence to National Standards and Improved Outcomes

Length of hospital stay after hip fracture and risk of early mortality after discharge in New York state: Retrospective cohort study

Mortality Rates of Patients with Proximal Femoral Fracture in a Worldwide Pandemic

COVID-19: not a contraindication for surgery in patients with proximal femur fragility fractures

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study